UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical infectious diseases, ISSN 1058-4838, 4/2009, Volume 48, Issue 8, pp. 1042 - 1051
Antifungals | Antibacterials | Induction chemotherapy | Sample size | Articles and Commentaries | Aspergillosis | Fungal infections | Consolidation chemotherapy | Fever | Neutropenia | Teaching hospitals | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Antibiotic Prophylaxis | Opportunistic Infections - prevention & control | Fever - physiopathology | Antifungal Agents - therapeutic use | Neutropenia - complications | Multicenter Studies as Topic | Statistics, Nonparametric | Amphotericin B - administration & dosage | Adult | Female | Deoxycholic Acid - administration & dosage | Mycoses - prevention & control | Risk Factors | Deoxycholic Acid - therapeutic use | Chi-Square Distribution | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Mycoses - diagnosis | Aged | Mycoses - complications | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Drug Combinations | Care and treatment | Patient outcomes | Dosage and administration | Research | Drug therapy | Hyperthermia | Survival analysis | Chemotherapy | Antibiotics | Mortality | Clinical trials | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 3/2012, Volume 67, Issue 3, pp. 715 - 722
Antifungal | Fungal infections | Combination therapy | Mould infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Mucormycosis - mortality | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Benzoates - administration & dosage | Drug Therapy, Combination - methods | Animals | Survival Analysis | Amphotericin B - administration & dosage | Adult | Female | Aged | Iron Chelating Agents - administration & dosage | Mice | Mucormycosis - drug therapy | Antifungal Agents - administration & dosage | Placebos - administration & dosage | Clinical trials | Drug therapy | Pathogenesis | Rodents | Mortality | Index Medicus | mould infections | antifungal | combination therapy | Original Research | fungal infections
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1291 - 1302
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - adverse effects | Meningitis, Cryptococcal - drug therapy | Humans | Kaplan-Meier Estimate | Induction Chemotherapy | Male | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Amphotericin B - adverse effects | Flucytosine - adverse effects | Flucytosine - therapeutic use | Adult | Female | Amphotericin B - therapeutic use | Drug Therapy, Combination | Drugs | Dose-response relationship (Biochemistry) | Usage | Cryptococcal meningitis | Amphotericin B | Patient outcomes | Flucytosine | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Yeast | Fluconazole | Medical treatment | Mortality | Body weight | Clinical trials | Cerebrospinal fluid | Survival | Patients | Tropical diseases | Hospitals | Consent | Human immunodeficiency virus--HIV | Meningitis | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2008, Volume 46, Issue 2, pp. 201 - 211
Antifungals | Logistic regression | Azoles | Articles and Commentaries | Aspergillosis | Drug monitoring | Infections | Fungal infections | Dosage | Pharmacokinetics | Blood | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Chromatography, High Pressure Liquid - methods | Triazoles - blood | Pyrimidines - blood | Humans | Middle Aged | Mycoses - microbiology | Male | Candidiasis - microbiology | Candidiasis - blood | Candidiasis - drug therapy | Voriconazole | Adult | Female | Mycoses - blood | Retrospective Studies | Aspergillosis - blood | Aspergillosis - drug therapy | Pyrimidines - administration & dosage | Aspergillosis - microbiology | Mycoses - drug therapy | Pyrimidines - adverse effects | Aged | Drug Monitoring | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Mycoses | Research | Drug therapy | Patient outcomes | Drug utilization | Studies | Pharmacology | Drug dosages | Chromatography | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 11/2005, Volume 41, Issue 10, pp. 1448 - 1452
Antifungals | Azoles | Major Articles | Polyenes | Aspergillosis | Medical specialists | Lipids | Experimentation | Fungal infections | Dosage | Salvage therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Antiparasitic agents | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Itraconazole - therapeutic use | Pyrimidines - therapeutic use | Humans | Salvage Therapy | Voriconazole | Deoxycholic Acid - therapeutic use | Treatment Outcome | Amphotericin B - therapeutic use | Drug Combinations | Antifungal Agents - therapeutic use | Aspergillosis - drug therapy | Triazoles - therapeutic use | Care and treatment | Amphotericin B | Diagnosis | Research | Comparative analysis | Risk factors | Drug therapy | Respiratory diseases | Clinical outcomes | Effectiveness studies | Index Medicus
Journal Article
2019, 2, ISBN 1498768148, 536
eBook
Journal of Crohn's and colitis, ISSN 1873-9946, 06/2014, Volume 8, Issue 6, pp. 443 - 468
Inflammatory bowel disease | ECCO guidelines | Opportunistic infections | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | HIV Infections - prevention & control | Hepatitis C - therapy | Age Factors | Herpesviridae Infections - etiology | Humans | Middle Aged | Opportunistic Infections - prevention & control | Opportunistic Infections - therapy | Papillomavirus Infections - diagnosis | Herpesviridae Infections - prevention & control | Papillomavirus Infections - therapy | Parasitic Diseases - etiology | Opportunistic Infections - etiology | Young Adult | Parasitic Diseases - therapy | HIV Infections - diagnosis | Mycoses - therapy | Adult | Influenza, Human - diagnosis | Papillomavirus Infections - etiology | Hepatitis C - prevention & control | Inflammatory Bowel Diseases - complications | Influenza, Human - therapy | Mycoses - prevention & control | Hepatitis B - therapy | Risk Factors | Parasitic Diseases - prevention & control | Herpesviridae Infections - diagnosis | Influenza, Human - etiology | Opportunistic Infections - diagnosis | Hepatitis B - diagnosis | Hepatitis B - etiology | Hepatitis C - diagnosis | HIV Infections - etiology | Herpesviridae Infections - therapy | Papillomavirus Infections - prevention & control | Adolescent | HIV Infections - therapy | Mycoses - diagnosis | Parasitic Diseases - diagnosis | Hepatitis B - prevention & control | Immunocompromised Host | Hepatitis C - etiology | Influenza, Human - prevention & control | Mycoses - etiology | Index Medicus
Journal Article
2014, ISBN 9780716532361, xi, 268 p., 8 p. of plates
Book
Journal of clinical oncology, ISSN 0732-183X, 03/2020, Volume 38, Issue 8, pp. 815 - 822
Hematologic Neoplasms - microbiology | Hematologic Neoplasms - therapy | Humans | Middle Aged | Fluconazole - administration & dosage | Male | Micafungin - administration & dosage | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Itraconazole - administration & dosage | Leukocyte Count | Mycoses - blood | Febrile Neutropenia - microbiology | Neutrophils - pathology | Mycoses - prevention & control | Febrile Neutropenia - blood | Febrile Neutropenia - drug therapy | Hematologic Neoplasms - blood | Hematologic Neoplasms - drug therapy | Aged | Hematopoietic Stem Cell Transplantation - methods | Antifungal Agents - administration & dosage | Mycoses - etiology | Index Medicus
Journal Article
Mycoses, ISSN 0933-7407, 03/2019, Volume 62, Issue 3, pp. 196 - 203
antifungal | patient safety | parenteral antifungal therapy | invasive candidosis | outpatient parenteral antimicrobial therapy | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Ambulatory Care - methods | Administration, Intravenous | Antifungal Agents - administration & dosage | Humans | Mycoses - drug therapy | Mycoses | Antifungal agents | Intolerance | Intravenous administration | Fungal infections | Patients | Index Medicus
Journal Article
Microbiological research, ISSN 0944-5013, 2008, Volume 163, Issue 1, pp. 1 - 12
Yeasts | Photosensitisers | Photodynamic antimicrobial chemotherapy | Dermatomycetes | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aminolevulinic Acid - chemistry | Photosensitizing Agents - chemistry | Porphyrins - therapeutic use | Humans | Porphyrins - chemistry | Aminolevulinic Acid - therapeutic use | Photochemotherapy | Fungi | Photosensitizing Agents - administration & dosage | Radiation-Sensitizing Agents - therapeutic use | Animals | Mycoses - drug therapy | Indoles - therapeutic use | Antifungal Agents | Radiation-Sensitizing Agents - chemistry | Indoles - chemistry | Chemotherapy | Phthalocyanins | Antifungal agents | Mycoses | Health aspects | Porphyrins | Dyes and dyeing | Cancer | Index Medicus
Journal Article
Diagnostic microbiology and infectious disease, ISSN 0732-8893, 2012, Volume 73, Issue 4, pp. 293 - 300
Infectious Disease | Internal Medicine | Aspergillus | Candida | Invasive fungal infections | Mucormycetes | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Mycology | Biological and medical sciences | Medical sciences | Microbiological Techniques - methods | Mycoses - epidemiology | Humans | Mycoses - drug therapy | Survival Analysis | Mycoses - microbiology | International Cooperation | Mycoses - mortality | North America - epidemiology | Antifungal Agents - therapeutic use | Fluconazole | Stem cells | Antifungal agents | Mycoses | Transplantation | Health aspects | Hematopoietic stem cells | Index Medicus
Journal Article